Longevity Briefing
A curated daily readout of the science, companies, capital flows, and policy moves shaping longevity.
KEANAISSANCE convenes a tightly curated group of founders, investors, clinicians, and operators in a setting designed to accelerate execution in the longevity economy. By removing the audience layer and focusing on decision-makers with direct agency, it creates an environment where capital, science, and delivery can align more quickly. The result is not just discussion, but a higher probability of real partnerships, capital deployment, and tangible progress.
Trending Now
Based on last 48h engagement
More from Masters of Longevity
On April 8, the streets of Madrid were not the scene of an ordinary protest. Citizens, scientists, entrepreneurs, and healthcare professionals gathered for the Longevity March, a global mobilization that connected Madrid simultaneously with major cities such as Brussels, London, Paris, and Berlin in Europe; Caracas, Mexico City, and San Francisco in the Americas; and Abu Dhabi and Tel Aviv in the Middle East, even during the current war in the region. The message was clear and urgent: aging must be treated as a global political and scientific priority.
The gut microbiome has become a scientific and public fascination, with new studies and health claims emerging daily. While diet is often cited as the key factor shaping gut bacteria, research suggests a far more complex picture. With over 200 variables influencing an individual’s microbiome and only a fraction of its variability explained, the idea of a universally “healthy” gut remains elusive. Popular microbiome tests and interventions may not tell the whole story – especially when stool samples only offer a partial snapshot of the vast intestinal ecosystem. This article explores the intricate relationship between diet, microbiome diversity, and health, challenging common assumptions and highlighting the unanswered questions in this rapidly evolving field.
The Swiss healthcare system is frequently cited as one of the most robust, high-quality, and accessible systems in the world. However, a closer examination of its financial architecture reveals a system fundamentally misaligned with the emerging paradigm of longevity and preventive health. It’s a system optimized for “Sick Care” – the management of acute pathology and established chronic disease – but structurally fails to preserve health capital. This report dissects the structural and economic forces behind this dynamic and explores what would need to change to enable a transition toward a prevention- and longevity-driven healthcare system.
APC analysis of Chinese elders shows frailty rises with age, falls across later birth cohorts, recent period effects increased frailty, and projections predict worsening with gender and urban–rural gaps.
Why it matters Projected increases in frailty, especially among urban older women and growing rural burdens, signal rising demand for long-term care, integrated.
Rising global cancer rates require integrated prevention, early detection, and tailored national planning, while expanded screening demands careful balancing of harms, uptake, and sustainable funding.
Why it matters Policy choices on screening, prevention, and funding will shape health-system costs, regulatory priorities, and market opportunities for diagnostics.
Survey assessed awareness and uptake of low-dose CT lung cancer screening among Lebanese current and former smokers aged 40 and older and found low awareness and limited uptake.
Why it matters High smoking prevalence and a substantial lung cancer burden in Lebanon create a pressing need for effective secondary prevention.
Review positions water kefir as a simple plant-based microbial community for multi-omics studies and genome-scale metabolic modelling, offering a roadmap to design defined starter cultures and address regulatory hurdles.
Why it matters Presents a practical framework to convert artisanal water kefir into defined, functional starter cultures suitable for controlled industrial.
